3-[(2,4-dimethyl-benzoyl)-(4-oxo-cyclohexyl)-amino]-5-(3,3-dimethyl-but-1-ynyl)-thiophene-2-carboxylic acid methyl ester | 1309853-35-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-[(2,4-dimethyl-benzoyl)-(4-oxo-cyclohexyl)-amino]-5-(3,3-dimethyl-but-1-ynyl)-thiophene-2-carboxylic acid methyl ester
• 英文别名: methyl 3-[(2,4-dimethylbenzoyl)-(4-oxocyclohexyl)amino]-5-(3,3-dimethylbut-1-ynyl)thiophene-2-carboxylate
• CAS: 1309853-35-7
• 化学式: C₂₇H₃₁NO₄S
• 分子量: 465.613
• InChiKey: NFNRSTJPUOUUDT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.9
• 重原子数：
  33
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  91.9
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3-[(2,4-dimethyl-benzoyl)-(4-oxo-cyclohexyl)-amino]-5-(3,3-dimethyl-but-1-ynyl)-thiophene-2-carboxylic acid methyl ester 在 sodium tetrahydroborate 、 lithium hydroxide monohydrate 、 水 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 0.5h， 生成 3-[(2,4-dimethyl-benzoyl)-(trans-4-hydroxy-cyclohexyl)-amino]-5-(3,3-dimethyl-but-1-ynyl)-thiophene-2-carboxylic acid
  参考文献：
  名称：

  [EN] 5-ALKYNYL-THIOPHENE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
  [FR] DÉRIVÉS D'ACIDE 5-ALCYNYL-THIOPHÈNE-2-CARBOXYLIQUE ET LEUR UTILISATION POUR TRAITER OU PRÉVENIR DES INFECTIONS À FLAVIVIRUS

  摘要：

  由公式(I)代表的化合物或其药用可接受的盐，其中R1、R2和R3如本文所定义，对治疗黄病毒科病毒感染有用。

  公开号：

  WO2011068715A1
• 作为产物：
  描述：

  methyl 3-amino-5-(3,3-dimethylbut-1-ynyl)thiophene-2-carboxylate 在 吡啶 、 盐酸 、 三乙酰氧基硼氢化钠 、 溶剂黄146 作用下， 以 四氢呋喃 、 水 、 甲苯 为溶剂， 生成 3-[(2,4-dimethyl-benzoyl)-(4-oxo-cyclohexyl)-amino]-5-(3,3-dimethyl-but-1-ynyl)-thiophene-2-carboxylic acid methyl ester
  参考文献：
  名称：

  [EN] 5-ALKYNYL-THIOPHENE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
  [FR] DÉRIVÉS D'ACIDE 5-ALCYNYL-THIOPHÈNE-2-CARBOXYLIQUE ET LEUR UTILISATION POUR TRAITER OU PRÉVENIR DES INFECTIONS À FLAVIVIRUS

  摘要：

  由公式(I)代表的化合物或其药用可接受的盐，其中R1、R2和R3如本文所定义，对治疗黄病毒科病毒感染有用。

  公开号：

  WO2011068715A1

文献信息

• COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRIDAE VIRAL INFECTIONS
  申请人：VERTEX PHARMACEUTICALS INCORPORATED

  公开号：US20140065103A1

  公开（公告）日：2014-03-06

  A compound is selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier of excipient. A method of treating a HCV infection in a subject comprises administering to the subject a therapeutically effective amount of selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof. A method of inhibiting or reducing the activity of HCV polymerase in a subject or in a biological in vitro sample comprises administering to the subject or to the sample a therapeutically effective amount of selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof.

  从图1所示的结构式中选择一个化合物或其药学上可接受的盐。一种制药组合物包括从图1所示的结构式中选择的化合物或其药学上可接受的盐，以及药学上可接受的载体或赋形剂。一种治疗HCV感染的方法包括向受试者施用从图1所示的结构式中选择的化合物或其药学上可接受的盐的治疗有效量。一种抑制或减少受试者或体外生物样品中HCV聚合酶活性的方法包括向受试者或样品施用从图1所示的结构式中选择的化合物或其药学上可接受的盐的治疗有效量。
• COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
  申请人：Chan Chun Kong Laval

  公开号：US20130136719A1

  公开（公告）日：2013-05-30

  Compounds represented by formula I: or pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , and R 3 are as defined herein, are useful for treating flaviviridae viral infections.

  公式I所代表的化合物或其药学上可接受的盐，其中R1、R2和R3的定义如本文所述，可用于治疗黄病毒科病毒感染。
• 5-ALKYNYL-THIOPHENE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：EP2504329A1

  公开（公告）日：2012-10-03
• [EN] COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRIDAE VIRAL INFECTIONS<br/>[FR] COMPOSÉS ET MÉTHODES DE TRAITEMENT OU DE PRÉVENTION D'INFECTIONS VIRALES PAR DES FLAVIVIRIDAE
  申请人：VERTEX PHARMA

  公开号：WO2012024363A2

  公开（公告）日：2012-02-23

  A compound is selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier of excipient. A method of treating a HCV infection in a subject comprises administering to the subject a therapeutically effective amount of selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof. A method of inhibiting or reducing the activity of HCV polymerase in a subject or in a biological in vitro sample comprises administering to the subject or to the sample a therapeutically effective amount of selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof.
• [EN] 5-ALKYNYL-THIOPHENE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS<br/>[FR] DÉRIVÉS D'ACIDE 5-ALCYNYL-THIOPHÈNE-2-CARBOXYLIQUE ET LEUR UTILISATION POUR TRAITER OU PRÉVENIR DES INFECTIONS À FLAVIVIRUS
  申请人：VERTEX PHARMA

  公开号：WO2011068715A1

  公开（公告）日：2011-06-09

  Compounds represented by formula (I) :or pharmaceutically acceptable salts thereof, wherein R1, R2, and R3 are as defined herein, are useful for treating flaviviridae viral infections.

  由公式(I)代表的化合物或其药用可接受的盐，其中R1、R2和R3如本文所定义，对治疗黄病毒科病毒感染有用。